Shoshana Shendelman's Insider Trades & SAST Disclosures
Shoshana Shendelman's most recent trade in Applied Therapeutics Inc was a trade of 747,886 Common Stock done . Disclosure was reported to the exchange on Aug. 5, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Shoshana Shendelman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Aug 2024 | 747,886 | 747,886 (4%) | 4% | 0 | Common Stock | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Aug 2024 | 747,886 | 0 (0%) | 4% | 0 | Common Stock | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.18 per share. | 05 Aug 2024 | 357,423 | 4,810,430 (25%) | 1% | 6.2 | 2,208,874 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.98 per share. | 05 Aug 2024 | 300,000 | 5,167,853 (27%) | 1% | 6.0 | 1,794,000 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.93 per share. | 05 Aug 2024 | 119,591 | 4,690,839 (25%) | 0% | 5.9 | 709,175 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.32 per share. | 06 Jun 2024 | 61,795 | 3,756,019 (20%) | 0% | 4.3 | 266,954 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.39 per share. | 14 Mar 2024 | 318,573 | 3,817,814 (20%) | 1% | 5.4 | 1,717,108 | Common Stock |
| Applied Therapeutics Inc | Shendelman Shoshana | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 1,100,000 | 3,696,387 (19%) | 5% | 0 | Common Stock | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 440,000 | 4,136,387 (22%) | 2% | 0 | Common Stock | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.97 per share. | 30 Nov 2023 | 3,968 | 2,596,387 (14%) | 0% | 2.0 | 7,817 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.70 per share. | 27 Sep 2023 | 115,632 | 2,600,355 (14%) | 0% | 2.7 | 312,206 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2023 | 1,964,362 | 2,715,987 (14%) | 10% | 0 | Common Stock | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.91 per share. | 11 Jan 2023 | 15,870 | 751,625 (4%) | 0% | 0.9 | 14,442 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 14 Oct 2022 | 50,000 | 767,495 (4%) | 0% | 0.6 | 32,250 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 13 Oct 2022 | 73,256 | 717,495 (3%) | 0% | 0.6 | 40,891 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.52 per share. | 12 Oct 2022 | 38,153 | 644,239 (3%) | 0% | 0.5 | 19,943 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 607,484 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 607,484 | 607,484 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 234,616 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 234,616 | 234,616 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 134,979 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 134,979 | 134,979 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 101,670 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 101,670 | 101,670 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 23,317 | 23,317 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 23,317 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 234,616 | 234,616 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 120,900 | 606,086 (3%) | 0% | 0 | Common Stock | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 80,600 | 80,600 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 120,900 | 485,186 (2%) | 0% | 0 | Common Stock | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 80,600 | 80,600 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.49 per share. | 13 Sep 2021 | 9,300 | 364,286 (1%) | 0% | 14.5 | 134,740 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.69 per share. | 13 Sep 2021 | 701 | 354,986 (1%) | 0% | 14.7 | 10,298 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 256,850 | 256,850 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 20 Jul 2020 | 15,000 | 569,285 (3%) | 0% | 1.4 | 21,600 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2020 | 15,000 | 539,609 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2020 | 15,000 | 554,609 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2020 | 15,000 | 569,609 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 20 Jul 2020 | 15,000 | 569,285 (3%) | 0% | 1.4 | 21,600 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 20 Jul 2020 | 15,000 | 569,285 (3%) | 0% | 1.4 | 21,600 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.19 per share. | 20 Jul 2020 | 12,100 | 557,185 (3%) | 0% | 27.2 | 328,999 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.45 per share. | 20 Jul 2020 | 12,051 | 557,235 (3%) | 0% | 25.5 | 306,698 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.69 per share. | 20 Jul 2020 | 7,600 | 561,685 (3%) | 0% | 26.7 | 202,844 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.42 per share. | 20 Jul 2020 | 7,300 | 554,385 (2%) | 0% | 27.4 | 200,166 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.51 per share. | 20 Jul 2020 | 2,949 | 554,285 (2%) | 0% | 26.5 | 78,178 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.88 per share. | 20 Jul 2020 | 2,600 | 554,585 (2%) | 0% | 27.9 | 72,488 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 28.64 per share. | 20 Jul 2020 | 300 | 554,285 (2%) | 0% | 28.6 | 8,592 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 28.24 per share. | 20 Jul 2020 | 100 | 554,285 (2%) | 0% | 28.2 | 2,824 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 07 Jul 2020 | 15,000 | 569,285 (3%) | 0% | 1.4 | 21,600 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 07 Jul 2020 | 15,000 | 569,285 (3%) | 0% | 1.4 | 21,600 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 07 Jul 2020 | 15,000 | 569,285 (3%) | 0% | 1.4 | 21,600 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2020 | 15,000 | 614,605 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2020 | 15,000 | 599,605 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2020 | 15,000 | 584,605 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.25 per share. | 07 Jul 2020 | 13,005 | 554,285 (2%) | 0% | 32.2 | 419,411 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.21 per share. | 07 Jul 2020 | 12,889 | 556,396 (3%) | 0% | 32.2 | 415,155 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.90 per share. | 07 Jul 2020 | 10,936 | 558,349 (3%) | 0% | 30.9 | 337,922 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.64 per share. | 07 Jul 2020 | 4,064 | 554,285 (2%) | 0% | 31.6 | 128,585 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.98 per share. | 07 Jul 2020 | 2,111 | 554,285 (2%) | 0% | 33.0 | 69,621 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.63 per share. | 07 Jul 2020 | 1,995 | 567,290 (3%) | 0% | 31.6 | 63,102 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 28 May 2020 | 709,720 | 709,720 (3%) | 3% | 0 | Common Stock | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 28 May 2020 | 709,720 | 2,304,285 (12%) | 3% | 0 | Common Stock | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 28 May 2020 | 290,280 | 3,014,005 (16%) | 1% | 0 | Common Stock | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 28 May 2020 | 290,280 | 290,280 (1%) | 1% | 0 | Common Stock | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 42.70 per share. | 28 May 2020 | 125,000 | 554,285 (2%) | 0% | 42.7 | 5,337,500 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 28 May 2020 | 97,376 | 679,285 (3%) | 0% | 1.4 | 140,221 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2020 | 97,376 | 629,605 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 28 May 2020 | 27,624 | 581,909 (3%) | 0% | 1 | 27,624 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2020 | 27,624 | 0 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges